Platelet Pathogen Reduction Technology-Should We Stay or Should We Go…?
Piccin, Andrea, Allameddine, Allameddine, Spizzo, Gilbert, Lappin, Katrina M, Prati, Daniele
Published in Journal of clinical medicine (10.09.2024)
Published in Journal of clinical medicine (10.09.2024)
Get full text
Journal Article
Effect of Deferasirox Combined with Erythropoietin Versus Erythropoietin Alone on Erythroid Response in Patients with Low- and Int-1-Risk Myelodysplastic Syndromes: Results of the Phase II Kallisto Trial
Gattermann, Norbert, Coll, Rosa, Jacobasch, Lutz, Allameddine, Allameddine, DeBonnett, Laurie, Azmon, Amin, Jin, Jie
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int‐1‐risk MDS patients: Results of the phase II KALLISTO trial
Gattermann, Norbert, Coll, Rosa, Jacobasch, Lutz, Allameddine, Allameddine, Azmon, Amin, DeBonnett, Laurie, Bruederle, Andreas, Jin, Jie
Published in European journal of haematology (01.08.2018)
Published in European journal of haematology (01.08.2018)
Get full text
Journal Article
47 Triple Negative Breast Cancer – Experience of a Single Tertiary Center
Allameddine, R, Shamseddine, A, Mukherji, D, Elias, E, Faraj, W, Hattoum, H, Saleh, A, El Saghir, N.S
Published in European journal of cancer (1990) (01.03.2012)
Published in European journal of cancer (1990) (01.03.2012)
Get full text
Journal Article